Mein Warenkorb

Biotinylated Cynomolgus IL-33 Protein, His,Avitag™ (HPLC verified)

User Reviews
Product Number/Spec
Price
Menge
IL3-C82E3-25ug
$350.00
IL3-C82E3-200ug (100ug X 2)
$1380.00
ETA of in-stock products:2 business days
Gesamtanzahl Product Amount$ 0

Product Details

  • Synonyms

    IL33, DV27, C9ORF26, IL1F11, NFHEV, DKFZp586H0523, DVS27, NFEHEV, RP11-575C20.2

  • Source

    Biotinylated Cynomolgus IL-33 Protein, His,Avitag (IL3-C82E3) is expressed from human 293 cells (HEK293). It contains AA His 109 - Ile 270 (Accession # A0A2K5W3I1-1).

    Predicted N-terminus: His 109

    Request for sequence
  • Molecular Characterization

    IL-33 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 21.9 kDa. The protein migrates as 27 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-HPLC.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

Data Display

  • SDS-PAGE

    IL-33 SDS-PAGE

    Biotinylated Cynomolgus IL-33 Protein, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-HPLC

    IL-33 SEC-HPLC

    The purity of Biotinylated Cynomolgus IL-33 Protein, His,Avitag (Cat. No. IL3-C82E3) was greater than 95% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     IL-33 ELISA

    Immobilized Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus IL-33 Protein, His,Avitag (Cat. No. IL3-C82E3) with a linear range of 0.2-2 ng/mL (QC tested).

    Protocol
  • Bioactivity-BLI

     IL-33 BLI

    Loaded Biotinylated Cynomolgus IL-33 Protein, His,Avitag (Cat. No. IL3-C82E3) on SA Biosensor, can bind Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) with an affinity constant of 2.97 nM as determined in BLI assay (ForteBio Octet RED96e) (Routinely tested).

    Protocol
  •  IL-33 BLI

    Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind Biotinylated Cynomolgus IL-33 Protein, His,Avitag (Cat. No. IL3-C82E3) with an affinity constant of 9.68 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

User Reviews
Publish Comment

Background Introduction

Interleukin 33 (IL33) is known as C9orf26, DKFZp586H0523, DVS27, NF-HEV, NFEHEV, RP11-575C20.2,and is a cytokine belonging to the IL-1 superfamily. IL-33 induces helper T cells, mast cells, eosinophils and basophils to produce type 2 cytokines. IL-33 mediates its biological effects by interacting with the receptors ST2 (aka IL1RL1) and IL-1 Receptor Accessory Protein (IL1RAP), activating intracellular molecules in the NF-κB and MAP kinase signaling pathways that drive production of type 2 cytokines (e.g. IL-5 and IL-13) from polarized Th2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.

Frontier Progress

 
Drug Development Progress
  • English Name:

    Interleukin-33

  • Category:

  • Listed Drugs Count:

    0 Details

  • Clinical Drugs Count:

    9 Details

  • Highest R&D Stage:

    Phase 3 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
  • Hintergrund
Kontaktieren Sie uns